Literature DB >> 20730800

Acute and long-term response of dopamine nigrostriatal synapses to a single, low-dose episode of 3-nitropropionic acid-mediated chemical hypoxia.

Cynthia A Crawford1, Garnik Akopian, Justin Ring, Michael W Jakowec, Giselle M Petzinger, Julie K Andersen, Philip Vittozzi-Wong, Kristie Wang, Cristal M Farley, Sergios Charntikov, Danut Mitroi, M Flint Beal, Robert Chow, John P Walsh.   

Abstract

The goal of the present investigation was to determine the persistence of striatal (DA) dopaminergic dysfunction after a mild chemically induced hypoxic event in Fisher 344 rats. To this end, we gave a single injection of the mitochondrial complex II inhibitor 3-nitropropionic acid (3-NP; 16.5 mg/kg, i.p.) to 2-month old male F344 rats and measured various indices of striatal DA functioning and lipid peroxidation over a 3-month span. Separate groups of rats were used to measure rod walking, evoked DA release, DA content, malondialdehyde (MDA) accumulation, DA receptor binding, and tyrosine hydroxylase (TH) activity. The results showed that 3-NP exposure reduced most measures of DA functioning including motoric ability, DA release, and D(2) receptor densities for 1 to 3 months postdrug administration. Interestingly, DA content was reduced 1 week after 3-NP exposure, but rose to 147% of control values 1 month after 3-NP treatment. MDA accumulation, a measure of lipid peroxidation activity, was increased 24 h and 1 month after 3-NP treatment. 3-NP did not affect TH activity, suggesting that alterations in DA functioning were not the result of nigrostriatal terminal loss. These data demonstrate that a brief mild hypoxic episode caused by 3-NP exposure has long-term detrimental effects on the functioning of the nigrostriatal DA system.
Copyright © 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20730800      PMCID: PMC3032029          DOI: 10.1002/syn.20852

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  69 in total

Review 1.  Neuronal cell death in Huntington's disease: a potential role for dopamine.

Authors:  R J Jakel; W F Maragos
Journal:  Trends Neurosci       Date:  2000-06       Impact factor: 13.837

2.  Reduced extracellular dopamine and increased responsiveness to novelty: neurochemical and behavioral sequelae of intermittent hypoxia.

Authors:  Michael J Decker; Karra A Jones; Inez G Solomon; Glenda L Keating; David B Rye
Journal:  Sleep       Date:  2005-02       Impact factor: 5.849

3.  Subacute systemic 3-nitropropionic acid intoxication induces a distinct motor disorder in adult C57Bl/6 mice: behavioural and histopathological characterisation.

Authors:  P O Fernagut; E Diguet; N Stefanova; M Biran; G K Wenning; P Canioni; B Bioulac; F Tison
Journal:  Neuroscience       Date:  2002       Impact factor: 3.590

4.  Amphetamine-sensitized animals show a marked increase in dopamine D2 high receptors occupied by endogenous dopamine, even in the absence of acute challenges.

Authors:  Philip Seeman; Teresa Tallerico; Françoise Ko; Catherine Tenn; Shitij Kapur
Journal:  Synapse       Date:  2002-12-15       Impact factor: 2.562

5.  Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections.

Authors:  T G Hastings; D A Lewis; M J Zigmond
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-05       Impact factor: 11.205

6.  Evolution of dopamine receptors in the rat after neonatal hypoxia-ischemia: autoradiographic studies.

Authors:  A Zouakia; D Guilloteau; L Zimmer; J C Besnard; S Chalon
Journal:  Life Sci       Date:  1997       Impact factor: 5.037

7.  The temporal evolution of striatal dopamine receptor binding and mRNA expression following hypoxia-ischemia in the neonatal rat.

Authors:  F M Filloux; J Adair; N Narang
Journal:  Brain Res Dev Brain Res       Date:  1996-06-14

8.  Chronic intoxication with 3-nitropropionic acid in rats induces the loss of striatal dopamine terminals without affecting nigral cell viability.

Authors:  David Blum; Marie-Christine Galas; Laetitia Cuvelier; Serge N Schiffmann
Journal:  Neurosci Lett       Date:  2004-01-16       Impact factor: 3.046

9.  Systemic 3-nitropropionic acid: long-term effects on locomotor behavior.

Authors:  T K Koutouzis; C V Borlongan; T Scorcia; I Creese; D W Cahill; T B Freeman; P R Sanberg
Journal:  Brain Res       Date:  1994-05-23       Impact factor: 3.252

10.  Up-regulation of dopamine D(2)L mRNA levels in the ventral tegmental area and dorsal striatum of amphetamine-sensitized C57BL/6 mice: role of Ca(v)1.3 L-type Ca(2+) channels.

Authors:  T P Giordano; S S Satpute; J Striessnig; B E Kosofsky; A M Rajadhyaksha
Journal:  J Neurochem       Date:  2006-10-05       Impact factor: 5.372

View more
  4 in total

1.  Behavioral effects of dopamine receptor inactivation in the caudate-putamen of preweanling rats: role of the D2 receptor.

Authors:  Taleen Der-Ghazarian; Crystal B Widarma; Arnold Gutierrez; Leslie R Amodeo; Joseph M Valentine; Danielle E Humphrey; Ashley E Gonzalez; Cynthia A Crawford; Sanders A McDougall
Journal:  Psychopharmacology (Berl)       Date:  2013-09-22       Impact factor: 4.530

2.  Brief mitochondrial inhibition causes lasting changes in motor behavior and corticostriatal synaptic physiology in the Fischer 344 rat.

Authors:  G Akopian; C Crawford; G Petzinger; M W Jakowec; J P Walsh
Journal:  Neuroscience       Date:  2012-04-30       Impact factor: 3.590

3.  Behavioral effects of dopamine receptor inactivation during the adolescent period: age-dependent changes in dorsal striatal D2(High) receptors.

Authors:  Sanders A McDougall; Joseph M Valentine; Ashley E Gonzalez; Danielle E Humphrey; Crystal B Widarma; Cynthia A Crawford
Journal:  Psychopharmacology (Berl)       Date:  2013-11-28       Impact factor: 4.530

4.  Dopamine receptor inactivation in the caudate-putamen differentially affects the behavior of preweanling and adult rats.

Authors:  T Der-Ghazarian; A Gutierrez; F A Varela; M S Herbert; L R Amodeo; S Charntikov; C A Crawford; S A McDougall
Journal:  Neuroscience       Date:  2012-09-19       Impact factor: 3.590

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.